圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02257 圣诺医药-B

已收盘 04-19 16:08:35

5.800

-0.280

-4.61%

最高6.200	最低5.750	成交量228.56万
今开6.200	昨收6.080	日振幅7.40%
总市值5.08亿	流通市值5.08亿	总股本8,764万
成交额1,337万	换手率2.61%	流通股本8,764万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02257","market":"HK","secType":"STK","nameCN":"圣诺医药-B","latestPrice":5.8,"timestamp":1713514115032,"preClose":6.08,"halted":0,"volume":2285600,"delay":0,"floatShares":87638480,"shares":87638480,"eps":-8.104271,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.28,"latestTime":"04-19 16:08:35","open":6.2,"high":6.2,"low":5.75,"amount":13366387,"amplitude":0.074013,"askPrice":5.8,"askSize":22000,"bidPrice":5.75,"bidSize":5050,"shortable":3,"etf":0,"ttmEps":-8.104271268221233,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1640793600000,"adjPreClose":6.08,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.289486,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02257","defaultTab":"news","newsList":[{"id":"2428500882","title":"圣诺医药-B盘中异动 急速下跌5.10%报5.770港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428500882","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428500882?lang=zh_cn&edition=full","pubTime":"2024-04-19 13:29","pubTimestamp":1713504582,"startTime":"0","endTime":"0","summary":"2024年04月19日下午盘13时29分，圣诺医药-B股票出现波动，股价大幅跳水5.10%。截至发稿，该股报5.770港元/股，成交量141.145万股，换手率1.61%，振幅7.07%。资金方面，该股资金流入196.1万港元，流出410.27万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。圣诺医药-B股票所在的生物技术行业中，整体跌幅为0.94%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041913294287e82104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041913294287e82104&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428507070","title":"圣诺医药－Ｂ(02257)股价下跌5.099%，现价港币$5.77","url":"https://stock-news.laohu8.com/highlight/detail?id=2428507070","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428507070?lang=zh_cn&edition=full","pubTime":"2024-04-19 13:29","pubTimestamp":1713504540,"startTime":"0","endTime":"0","summary":"[下跌股]圣诺医药－Ｂ(02257) 股价在下午01:29比前收市价下跌5.099%，现股价为港币$5.77。至目前为止，今日最高价为$6.2，而最低价为$5.77。总成交量为139.56万股，总成交金额为港币$822.169万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404193126/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428551284","title":"圣诺医药-B04月18日主力资金流出125万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428551284","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428551284?lang=zh_cn&edition=full","pubTime":"2024-04-18 16:15","pubTimestamp":1713428150,"startTime":"0","endTime":"0","summary":"04月18日, 圣诺医药-B股价跌2.09%，报收6.08元，成交金额3111万元，换手率5.76%，振幅11.27%，量比0.67。圣诺医药-B今日主力资金净流出125万元，连续3日净流出，上一交易日主力净流出72万元，今日环比增加73.61%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为5.28%。该股近5个交易日下跌16.18%，主力资金累计净流出41万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出956万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418161618878f0755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418161618878f0755&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428537364","title":"圣诺医药-B面临现金流枯竭危机：股价大涨背后的隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2428537364","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428537364?lang=zh_cn&edition=full","pubTime":"2024-04-18 14:30","pubTimestamp":1713421853,"startTime":"0","endTime":"0","summary":"摘要圣诺医药-B 股价大涨背后，现金流危机迫在眉睫。圣诺医药-B正面临着严峻的资金挑战。4月17日，圣诺医药股价开盘后大幅上涨，最高涨幅达37.87%。圣诺医药的现金流状况更是令人关注。在无产品商业化的情况下，圣诺医药的流动资金主要依赖于股权及债务融资。面对现金流枯竭的危机，圣诺医药可能需要寻找新的融资途径，或出售其核心产品STP705的商业化权益，以维持研发和运营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181440328b33fa01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181440328b33fa01&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428300727","title":"圣诺医药-B盘中异动 早盘股价大跌5.31%报5.880港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428300727","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428300727?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:37","pubTimestamp":1713404253,"startTime":"0","endTime":"0","summary":"2024年04月18日早盘09时37分，圣诺医药-B股票出现波动，股价急速下跌5.31%。截至发稿，该股报5.880港元/股，成交量65.975万股，换手率0.75%，振幅5.64%。资金方面，该股资金流入148.484万港元，流出151.534万港元。圣诺医药-B股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，瑞科生物-B、加科思-B、乐普生物-B涨幅较大，振幅较大的相关个股有圣诺医药-B、云顶新耀-B、荣昌生物，振幅分别为5.64%、5.62%、4.98%。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809373479215d84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809373479215d84&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428588228","title":"圣诺医药－Ｂ(02257)股价下跌5.314%，现价港币$5.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2428588228","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428588228?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:35","pubTimestamp":1713404100,"startTime":"0","endTime":"0","summary":"[下跌股]圣诺医药－Ｂ(02257) 股价在上午09:35比前收市价下跌5.314%，现股价为港币$5.88。至目前为止，今日最高价为$6.2，而最低价为$5.88。总成交量为53.275万股，总成交金额为港币$323.8万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240418122/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428395000","title":"现金流枯竭在即，圣诺医药-B(02257)冲高只为“套人”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2428395000","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428395000?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:33","pubTimestamp":1713342784,"startTime":"0","endTime":"0","summary":"股价一年内累跌九成，大股东上月被强制平仓，在这个节骨眼上，股价突然大涨逾20%，对圣诺医药-B来说或许并不是一件好事。4月17日，圣诺医药股价早盘高开，最高涨幅达到37.87%。消息面上，圣诺医药当日宣布，公司已获得美国FDA关于其核心品种STP705所要求的C类会议的书面答复。截至3月22日，戴晓畅所持股份降至235.66万股，占比降至2.49%。而在产品端，去年6月圣诺医药公告显示，治疗原位鳞状细胞癌的候选产品STP705进入后期临床研发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103861.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428355334","title":"圣诺医药(02257.HK)曾涨38% 治疗原位鳞状细胞癌疗法获美国FDA具体指导建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2428355334","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428355334?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:47","pubTimestamp":1713318420,"startTime":"0","endTime":"0","summary":"圣诺医药－Ｂ今日高开14.95%报6.92元，早段曾涨37.9%高见8.3元。现报7.38元，升22.59%，成交436.66万股，涉资3,315.2万元。公司公布，已获得美国食品药监局关于其用于进一步研发治疗原位鳞状细胞癌的新型siRNA疗法STP705所要求的C类会议的书面答复。FDA已为非临床及临床研究、对拟议的II/III期及III期临床研究的修订，以及在候选药物STP705中使用两种活性成分所需的进一步论证提供明确的具体指导建议。目前，公司已根据FDA的指导建议启动所需的临床前研究。沽空资料截至 2024-04-16 16:25。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220513155537706_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220513155537706_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1342846/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2428331738","title":"圣诺医药-B盘中异动 早盘快速拉升26.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428331738","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428331738?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:36","pubTimestamp":1713317796,"startTime":"0","endTime":"0","summary":"2024年04月17日早盘09时36分，圣诺医药-B股票出现异动，股价快速上涨26.25%。截至发稿，该股报7.600港元/股，成交量341.36万股，换手率3.90%，振幅22.92%。圣诺医药-B股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，圣诺医药-B、来凯医药-B、科济药业-B涨幅较大，振幅较大的相关个股有圣诺医药-B、来凯医药-B、荣昌生物，振幅分别为22.92%、7.36%、4.26%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417093637861e6687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417093637861e6687&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428339637","title":"圣诺医药-B高开近15% 治疗原位鳞癌的STP705获美国FDA具体指导建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2428339637","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2428339637?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:29","pubTimestamp":1713317399,"startTime":"0","endTime":"0","summary":"圣诺医药-B（02257）早盘上涨14.95%，现报6.92港元，成交额138.19万港元。\n　　圣诺医药今日宣布，公司已获得美国食品药品监督管理局（FDA）关于其用于进一步研发治疗原位鳞状细胞癌（isSCC）的新型siRNA疗法STP705所要求的C类会议的书面答复。所要求的C类会议的目的是获得FDA对拟议的非临床和临床开发计划的建议和意见，为治疗isSCC的II/III期及III期临床研究作准备。目前，公司已根据FDA的指导建议启动了所需的临床前研究。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-17/doc-inasazye8812498.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-17/doc-inasazye8812498.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428399173","title":"港股异动丨圣诺医药高开近15%，治疗原位鳞状细胞癌疗法获FDA具体指导建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2428399173","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428399173?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:25","pubTimestamp":1713317125,"startTime":"0","endTime":"0","summary":"圣诺医药-B高开14.95%报6.92港元。消息面上，公司公布已获得美国食品药监局关于其用于进一步研发治疗原位鳞状细胞癌的新型siRNA疗法STP705所要求的C类会议的书面答复。针对公司的建议以及与相关非临床研究及临床研究设计有关的问题，FDA已为非临床及临床研究、对拟议的II/III期及III期临床研究的修订，以及在候选药物STP705中使用两种活性成分所需的进一步论证提供明确的具体指导建议。目前，公司已根据FDA的指导建议启动所需的临床前研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170925548b2c9cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170925548b2c9cac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428339393","title":"港股异动 | 圣诺医药-B(02257)高开近15% 治疗原位鳞癌的STP705获美国FDA具体指导建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2428339393","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428339393?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:22","pubTimestamp":1713316947,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，圣诺医药-B高开近15%，截至发稿，涨14.95%，报6.92港元，成交额138.19万港元。消息面上，圣诺医药今日宣布，公司已获得美国食品药品监督管理局关于其用于进一步研发治疗原位鳞状细胞癌的新型siRNA疗法STP705所要求的C类会议的书面答复。目前，公司已根据FDA的指导建议启动了所需的临床前研究。据悉，圣诺医药管线中进展最快的是STP705，涉及鳞状细胞原位癌、基底细胞癌两项适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103669.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427755678","title":"圣诺医药-B(02257)：Sirnaomics用于治疗原位鳞状细胞癌的STP705的进一步研发获得FDA的具体指导建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2427755678","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2427755678?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:31","pubTimestamp":1713277871,"startTime":"0","endTime":"0","summary":"圣诺医药-B(02257)发布公告，公司已获得美国食品药品监督管理局(FDA)关于...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_4.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_4.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103609.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427868495","title":"迈博药业-B盘中异动 大幅下跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427868495","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427868495?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:53","pubTimestamp":1713232417,"startTime":"0","endTime":"0","summary":"2024年04月16日早盘09时53分，迈博药业-B股票出现波动，股价大幅跳水5.70%。截至发稿，该股报0.430港元/股，成交量2000股，换手率0.00%，振幅0.00%。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.28%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160953377920c034&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160953377920c034&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427513045","title":"圣诺医药－Ｂ(02257)股价大幅上升18.462%，现价港币$7.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2427513045","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427513045?lang=zh_cn&edition=full","pubTime":"2024-04-15 13:44","pubTimestamp":1713159840,"startTime":"0","endTime":"0","summary":"[上升股]圣诺医药－Ｂ(02257) 股价在下午01:44比前收市价大幅上升18.462%，现股价为港币$7.7。至目前为止，今日最高价为$7.7，而最低价为$5.93。总成交量为544.03万股，总成交金额为港币$3.654千万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404151367/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427804893","title":"圣诺医药－Ｂ(02257)股价显著波动13.846%，现价港币$6.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2427804893","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427804893?lang=zh_cn&edition=full","pubTime":"2024-04-15 13:10","pubTimestamp":1713157800,"startTime":"0","endTime":"0","summary":"[异动股]圣诺医药－Ｂ(02257) 股价在下午01:10出现显著波动13.846%，现股价为港币$6.81，比前收市价上升4.769%5.077%。至目前为止，今日最高价为$6.83，而最低价为$5.93。总成交量为221.23万股，总成交金额为港币$1.387千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC24041538/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427019009","title":"圣诺医药－Ｂ(02257)股价下跌8.308%，现价港币$5.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2427019009","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427019009?lang=zh_cn&edition=full","pubTime":"2024-04-15 11:20","pubTimestamp":1713151200,"startTime":"0","endTime":"0","summary":"[下跌股]圣诺医药－Ｂ(02257) 股价在上午11:20比前收市价下跌8.308%，现股价为港币$5.96。至目前为止，今日最高价为$6.68，而最低价为$5.96。总成交量为120.635万股，总成交金额为港币$743.878万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404152054/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427903130","title":"圣诺医药-B盘中异动 大幅下跌6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427903130","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427903130?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:46","pubTimestamp":1713145608,"startTime":"0","endTime":"0","summary":"2024年04月15日早盘09时46分，圣诺医药-B股票出现异动，股价大幅下跌6.15%。截至发稿，该股报6.100港元/股，成交量30.96万股，换手率0.35%，振幅8.92%。圣诺医药-B股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，永泰生物-B、百奥赛图-B、博安生物涨幅较大，振幅较大的相关个股有科济药业-B、圣诺医药-B、维亚生物，振幅分别为9.79%、8.92%、7.61%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041509464887e8025b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041509464887e8025b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426220063","title":"港股异动 | 圣诺医药-B(02257)午后跌超11%创新低 公司现金流告急 尚未有产品商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2426220063","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426220063?lang=zh_cn&edition=full","pubTime":"2024-04-12 13:58","pubTimestamp":1712901510,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，圣诺医药-B午后跌超11%再创新低。截至发稿，跌11.07%，报6.43港元，成交额1690.93万港元。消息面上，圣诺医药2023年财报显示，该公司期内取得其他收入141.4万美元，同比减少33.11%；股东应占亏损7869.1万美元，同比收窄10.88%。截止目前，圣诺医药尚未有产品实现商业化。值得注意的是，财报数据显示，圣诺医药的董事薪酬从2022年的191万美元增长至2023年的337万美元，同比大增76.44%。此外，2023年的员工薪酬增长主要来自非现金的股权奖励支出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101578.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426226830","title":"圣诺医药-B盘中异动 临近午盘急速下挫5.12%报6.861港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426226830","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426226830?lang=zh_cn&edition=full","pubTime":"2024-04-12 11:44","pubTimestamp":1712893444,"startTime":"0","endTime":"0","summary":"2024年04月12日临近午盘11时44分，圣诺医药-B股票出现波动，股价快速下跌5.12%。圣诺医药-B股票所在的生物技术行业中，整体跌幅为0.29%。其主要临床候选药物包括STP705和STP707。财报数据显示，圣诺医药的董事薪酬从2022年的191万美元增长至2023年的337万美元，同比大增76.44%。2021年12月，圣诺医药在港交所上市，募资净额为3.96亿港元。目前，圣诺医药尚未有产品实现商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121144047a524d9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121144047a524d9d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.sirnaomics.com/en/","stockEarnings":[{"period":"1week","weight":-0.1591},{"period":"1month","weight":-0.2576},{"period":"3month","weight":-0.8026},{"period":"6month","weight":-0.8737},{"period":"1year","weight":-0.8964},{"period":"ytd","weight":-0.8302}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"圣诺医药有限公司是一家主要从事临床阶段的核糖核酸（RNA）治疗生物制药公司。该公司从事发现和开发具有未满足医疗需求和市场机会的适应症的药物。该公司的产品在各种市场疾病中具有广泛的治疗作用，包括肿瘤、纤维化相关疾病以及抗病毒和心脏代谢疾病。该公司的目标一旦根据明确的科学原理选定，就会根据其对核糖核酸干扰所涉及的生化机制的理解，应用算法来确定针对选定目标基因的候选核糖核酸干扰触发序列，并采用高通量流程来设计、筛选和测试未来的管道产品。该公司有五项正在进行的I/II期临床试验，另外至少有14种候选产品正在进行新药研究的启用或高级临床前研究。","exchange":"SEHK","name":"圣诺医药-B","nameEN":"SIRNAOMICS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺医药-B,02257,圣诺医药-B股票,圣诺医药-B股票老虎,圣诺医药-B股票老虎国际,圣诺医药-B行情,圣诺医药-B股票行情,圣诺医药-B股价,圣诺医药-B股市,圣诺医药-B股票价格,圣诺医药-B股票交易,圣诺医药-B股票购买,圣诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}